Functional angiotensin II type 2 receptors inhibit growth factor signaling in LNCaP and PC3 prostate cancer cell lines. [electronic resource]
- The Prostate May 2008
- 651-60 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0270-4137
10.1002/pros.20738 doi
Cell Line, Tumor DNA--biosynthesis Epidermal Growth Factor--metabolism Gene Expression Regulation, Neoplastic--drug effects Humans Male Mitogen-Activated Protein Kinase 1--metabolism Phosphorylation Prostatic Neoplasms--genetics RNA, Messenger--metabolism RNA, Neoplasm--analysis Receptor, Angiotensin, Type 1--genetics Receptor, Angiotensin, Type 2--physiology Reverse Transcriptase Polymerase Chain Reaction Signal Transduction--drug effects